Journal
JOURNAL OF DIGESTIVE DISEASES
Volume 21, Issue 6, Pages 315-318Publisher
WILEY
DOI: 10.1111/1751-2980.12883
Keywords
extracellular matrix; inflammatory bowel diseases; intestinal fibrosis; mesenchymal cell
Categories
Funding
- National Natural Science Foundation of China [81873558] Funding Source: Medline
- Key Special Subproject of Research and Development of Digital Diagnosis and Treatment Equipment of National Key Research and Development Plan of the Ministry of Science and Technology, China [2018YFC0114604] Funding Source: Medline
Ask authors/readers for more resources
Intestinal fibrosis is a common complication of inflammatory bowel disease (IBD), resulting in strictures and ultimately obstruction, which is a significant clinical problem. Fibrosis is mainly triggered by local chronic inflammation and occurs when excessive extracellular matrix deposition is caused by activated mesenchymal cells. Despite the advance of anti-inflammatory therapies in IBD, the incidence and preventive strategies of intestinal fibrosis and strictures in IBD have not significantly changed over time. This shows that inflammation is necessary for fibrosis, but it does not necessarily affect the fibrotic progression. This review summarizes current knowledge about the non-inflammatory mechanisms implicated in the gut fibrotic process of IBD, which may pave the way for new mechanisms and anti-fibrotic therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available